Add BrightSurf on Google Email

Johns Hopkins Medicine


Cancer immunotherapy approach targets common genetic alteration

Researchers developed a new cancer immunotherapy that uses engineered T cells to target a genetic alteration common among all cancers. The approach stimulates an immune response against cells with the loss of one gene copy, called loss of heterozygosity (LOH), and has shown promising results in laboratory studies and mouse models.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateMar 15, 2021

Story tips from Johns Hopkins experts on COVID-19

A Johns Hopkins Medicine-led study evaluating over 9,500 Orthodox Jews in 12 states identified key factors contributing to the spread of COVID-19 within culturally bonded groups. The findings informed the development of safety guidelines for COVID-19-free celebrations among Orthodox Jewish communities.

SourceJohns Hopkins Medicine·JournalJAMA Network Open·DateMar 10, 2021

Story tips from Johns Hopkins experts on Covid-19

A study published in JAMA Neurology suggests that large bone marrow cells called megakaryocytes may be responsible for the lingering aftereffects of severe COVID-19 cases, including brain fog. The researchers found evidence of megakaryocytes in the brains of patients who died from COVID-19 and believe they may reduce blood flow to the ...

SourceJohns Hopkins Medicine·JournalJAMA Neurology·DateFeb 24, 2021

Story tips from Johns Hopkins experts on Covid-19

A commentary by Johns Hopkins experts highlights the need for standardized data collection and analysis to inform policy decisions and strategies. They propose creating a consensus task force to define metrics and refine them over time, enabling public health leaders and healthcare organizations to identify effective solutions.

SourceJohns Hopkins Medicine·JournalJournal of Hospital Medicine·DateFeb 9, 2021

Gut microbe may promote breast cancers

A study from Johns Hopkins Medicine reveals that exposure to B. fragilis toxin can increase the risk of breast cancer by leaving a lasting impression on cells. Researchers found that breast tissue cells exposed to the toxin retained a long-term memory, leading to tumor growth and metastasis in mice.

SourceJohns Hopkins Medicine·JournalCancer Discovery·DateJan 6, 2021